3 ms·
The issue in Type 1 Diabetes is autoimmune destruction of the islets of Langerhans, so the therapy would need to target the immune system.
by wbl 9y ago
The issue in Type 1 Diabetes is autoimmune destruction of the islets of Langerhans, so the therapy would need to target the immune system.